Current research is lacking in effective treatment strategies for patients with heavily pretreated metastatic renal cell carcinoma (mRCC). A study from Sebastiano Buti, MD, PhD, and colleagues published in Therapeutic Advances in Urology sought to determine the effectiveness and safety of lenvatinib plus everolimus for patients with mRCC. ...